Records containing: Neuromyelitis Optica
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-01-21Safety of Therapeutic Step-down in Neuromyelitis Optica
-
CLINICAL_TRIALS study record update · 2022-01-21A Lifestyle Weight Management Program for Paediatric Patients With Demyelinating Conditions: Interviews and Stakeholder Meetings.
-
CLINICAL_TRIALS study record update · 2021-12-27A Prospective Observational Study of Maintenance Plasma Exchange (PLEX) for Neuromyelitis Optica Spectrum Disorders (MultiPLEX Study)
-
CLINICAL_TRIALS study record update · 2020-12-28A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
-
CLINICAL_TRIALS study record update · 2020-10-23Study on the Association Between the Effect of Glucocorticoid Pulse Therapy on Neuromyelitis Optica and Gene Polymorphism: a Cohort Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-04-17Phase II, Randomized, Single Blind Sham Controlled Trial Investigating Scrambler Therapy for Neuropathic Pain Caused by Neuromyelitis Optica Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2020-02-27ClinicalTrials.gov study NCT02283671
-
CLINICAL_TRIALS study record update · 2019-12-17Immunologic Biomarker Profile of Cerebrospinal Fluid
-
CLINICAL_TRIALS study record update · 2019-11-20Autologous Hematopoietic Stem Cell Transplant for Neuromyelitis Optica Spectrum Disorder (NMOSD)
-
CLINICAL_TRIALS study record update · 2019-10-24Safety and Efficacy of Tocilizumab Versus Azathioprine in Neuromyelitis Optica Spectrum Disorders: a Randomized, Controlled, Open-label, Phase 2 Trial
-
CLINICAL_TRIALS study record update · 2019-06-26A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Trial to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO)
-
CLINICAL_TRIALS study record update · 2019-06-06Phase I, Single-Center, Open Label Trial of Ublituximab + Glucocorticoids for the Treatment of Acute Optic Neuritis and/or Transverse Myelitis in Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)
-
CLINICAL_TRIALS study record update · 2019-04-12A Single Center Open Label Pilot Study of Alpha1-Antitrypsin: A Novel Treatment to Mitigate Neuromyelitis Optica Attacks
-
CLINICAL_TRIALS study record update · 2018-05-02Autologous Hematopoietic Stem Cell Transplant in Patients With Neuromyelitis Optica
-
CLINICAL_TRIALS study record update · 2018-04-17Double-Blind, Placebo-Controlled Crossover Trial on the Safety and Efficacy of Sustained-Release Dalfampridine in Transverse Myelitis (Re-Launch)
-
CLINICAL_TRIALS study record update · 2016-07-20A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin (IVIg) Versus Standard Therapy for the Treatment of Transverse Myelitis in Adults and Children
-
CLINICAL_TRIALS study record update · 2015-05-29An Open-label Phase 1b Study of Avastin® (Bevacizumab) for the Treatment of Acute Optic Neuritis and/or Transverse Myelitis in Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD).
-
CLINICAL_TRIALS study record update · 2014-07-18Phase 1b Study of C1-esterase Inhibitor (Cinryze) With Standard of Care for Acute Treatment of Neuromyelitis Optica Exacerbations
-
CLINICAL_TRIALS study record update · 2013-12-27Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
-
CLINICAL_TRIALS study record update · 2013-11-04An Open Label Study of the Effects of Eculizumab in Neuromyelitis Optica
-
CLINICAL_TRIALS study record update · 2011-09-27Open Label Study of Safety and Tolerability of Rituximab in Neuromyelitis Optica, Recurrent Transverse Myelitis and Recurrent Bilateral Simultaneous Optic Neuritis
-
CLINICAL_TRIALS study record update · 2010-06-28Evaluation of Macular and Retinal Nerve Fiber Layer Thickness Measurements for Detection of Neural Loss in Multiple Sclerosis and Neuromyelitis Optica Using High Resolution Optical Coherence Tomography.